Studying at the University of Verona

Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.

Study Plan

A.A. 2026/2027 A.A. 2025/2026

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

1° Year

ModulesCreditsTAFSSD
6
B
MEDS-02/A
6
B
BIOS-07/A
One module among the following
6
B
BIOS-09/A
6
B
MEDS-01/A
6
B
MEDS-04/A
Three modules among the following
6
B
BIOS-08/A
6
B
BIOS-14/A
6
B
MEDS-03/A
6
B
BIOS-14/A
6
B
MEDS-03/A
6
B
BIOS-07/A

2° Year  It will be activated in the A.Y. 2027/2028

ModulesCreditsTAFSSD
2
F
-
12
D
-
Final exam
40
E
-
It will be activated in the A.Y. 2027/2028
ModulesCreditsTAFSSD
2
F
-
12
D
-
Final exam
40
E
-
Modules Credits TAF SSD
Between the years: 1°- 2°
One module among the following
- 1st year - Molecular pharmacology, Stem cells biology, Experimental Models in Biomedical Research - delivered in 2026/2027
- 2nd year - Forensic and analytical toxicology - delivered in 2027/2028
6
B
MEDS-26/A
6
B
BIOS-11/A
6
B
MEDS-09/B
6
B
MEDS-25/A
Between the years: 1°- 2°
Two modules among the following
- 1st year - Computational biology, Functional proteomics, Supramolecular chemistry of biological systems - delivered in 2026/2027 
- 2nd year - Chemistry at the interface of biology: approaches for biomolecular characterization - delivered in 2027/2028
6
B
BIOS-07/A
6
B
CHEM-01/A
6
B
CHEM-05/A
6
B
CHEM-05/A
Between the years: 1°- 2°
Two modules among the following
- 2nd year - Molecular farming, Toxicology, applied pharmacology, Systems biology - delivered in 2027/2028
- 1st and 2nd year - Radiation physics and radiochemistry for nuclear medicine and pharmaceutical applications, Biotechnology in Neuroscience, Clinical proteomics, Genetic counselling and experimental approaches in hereditary disorders - delivered in 2026/2027 and 2027/2028
6
C
BIOS-13/A
6
C
CHEM-01/A
6
C
BIOS-01/D
6
C
CHEM-03/A ,PHYS-03/A
6
C
BIOS-04/A ,MEDS-26/A
6
C
MEDS-02/A
6
C
BIOS-01/D

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.

A Basic activities
B Characterizing activities
C Related or complementary activities
D Activities to be chosen by the student
E Final examination
F Other training activities
S Placements in companies, public or private institutions and professional associations

Fisica delle radiazioni e radiochimica per la medicina nucleare e le applicazioni farmaceutiche (2026/2027)

Teaching code

4S014772

Credits

6

Coordinator

Francesca Monti

Language

English en

Also offered in courses:

Courses Single

Authorized

Seminars 0

The teaching is organized as follows:

NUCLEAR AND RADIATION PHYSICS en

Credits

4

Period

II semestre

Academic staff

Francesca Monti

Lessons timetable
MEDICINAL INORGANIC CHEMISTRY en

Credits

2

Period

II semestre

Academic staff

Chiara Nardon

Lessons timetable

Learning objectives

The course provides an introduction to the physical and chemical principles underlying the use of radiation and inorganic compounds in medicine. It integrates concepts from nuclear and radiation physics with elements of medicinal inorganic chemistry, with particular emphasis on the role of radioisotopes in diagnostic and therapeutic applications. The course is structured into two complementary modules. The first module aims to provide the fundamentals of nuclear physics, radioactivity, and radiation–matter interaction, which are necessary to understand the production and main applications of radioisotopes in medicine (imaging, radiotherapy, and brachytherapy), as well as the biological effects of ionizing radiation and the meaning of the related physical quantities. The second module focuses on coordination chemistry and the properties of radiolabelled compounds, addressing their use in nuclear medicine within well-defined biochemical and pathophysiological contexts. Clinically established agents and emerging systems at the preclinical stage are discussed, providing students with the fundamental concepts underlying the design of radiopharmaceuticals for applications such as cancer and cardiovascular diseases. Site visits may be included to illustrate real-world applications of the technologies discussed. Overall, the course aims to provide students with the knowledge required to understand the development and application of radiopharmaceuticals in a biomedical context.

Prerequisites and basic notions

Basic physical concepts

Criteria for the composition of the final grade

The grade obtained will be the average of the grades obtained in each of the two modules.